average weight loss on tirzepatide in 3 months What to Expect Tirzepatide: Month-by-Month Timeline What can 3 months on

Wegovy tablets will not be suitable for everyone

Here are the key results from Eli Lilly's fourth quarter earnings: Revenue: $9.35 billion, vs analyst estimates of $8.97 billion Adjusted EPS: $2.49, vs analyst estimates of $2.37 Mounjaro sales: $2.2 billion, vs analyst estimates of $1.8 billion Zepbound sales: $175.8 million, vs analyst estimates of $140.7 million Eli Lilly also offered 2024 revenue guidance of $40.4 billion to $41.6 billion, which was ahead of analyst estimates of $39.1 billion

Journal of the Endocrine Society , 5 (Supplement_1), A16A17.

There are fewer published studies concerning these effects with Tirzepatide, but current studies are promising, and there is some indication that it may help lower blood pressure which would have a positive cardiovascular effect